All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
IHE total return snapshot: IHE returned +51.11% over the past year and +19.23% YTD, with dividends reinvested. Since May 5, 2006, IHE is up +708.67% in nominal total return, or +10.91%/yr, and is currently −2.81% below its total-return high on Jul. 7, 2026.
Data ending Fri Jul. 10, 2026
| Fri 2006-05-05💬 to Fri 2026-07-10 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| IHE × |
+19.23%
2026-07-10 |
+51.11%
2026-07-10 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05💬 to Fri 2026-07-10 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IHE × |
+708.67%
+10.91%/yr |
+10.51%/yr
(R2=0.906) |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05💬 to Fri 2026-07-10 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| IHE × |
$10,000.00
2006-05-05 |
$80,867.33
2026-07-10 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Year | IHE |
|---|---|
| 2026 (YTD) | +19.23% |
| 2025 | +31.69% |
| 2024 | +8.13% |
| 2023 | +1.06% |
| 2022 | −4.87% |
| 2021 | +13.07% |
| 2020 | +13.66% |
| 2019 | +15.47% |
| 2018 | −7.76% |
| 2017 | +10.64% |
| 2016 | −11.75% |
| 2015 | +8.81% |
| 2014 | +29.90% |
| 2013 | +40.59% |
| 2012 | +13.38% |
| 2011 | +20.94% |
| 2010 | +12.71% |
| 2009 | +30.11% |
| 2008 | −14.92% |
| 2007 | +2.37% |
| 2006 | +6.50% |
| Fri 2006-05-05💬 to Fri 2026-07-10 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| IHE × |
−2.81%
from 2026-07-07 peak |
−38.20%
2009-03-05 from 2007-05-22 peak |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Period ending Fri 2026-07-10 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| IHE × | +51.11% |
+54.15% +24.16%/yr |
+81.70% +22.03%/yr |
+74.15% +11.73%/yr |
+135.38% +8.94%/yr |
|
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
